Bulletin
Investor Alert

June 16, 2022, 11:52 a.m. EDT

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of GT Biopharma, Inc. (GTBP)

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    GT Biopharma Inc. (GTBP)

or Cancel Already have a watchlist? Log In

Jun 16, 2022 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / June 16, 2022 / Levi & Korsinsky announces it has commenced an investigation of GT Biopharma, Inc. /zigman2/quotes/200365724/composite GTBP -4.36% concerning possible breaches of fiduciary duty. To obtain additional information, go to:

https://form.zlk.com/?id=2448&ac=MjAyMi0wNi0xNiAxMToyNDoxMg==&pv=1

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact the firm. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

COMTEX_408790283/2457/2022-06-16T11:51:30

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/200365724/composite
US : U.S.: Nasdaq
$ 2.63
-0.12 -4.36%
Volume: 82,843
Aug. 16, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$83.88 million
Rev. per Employee
N/A
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.